BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28430065)

  • 1. Ethical Issues in Fecal Microbiota Transplantation in Practice.
    Ma Y; Liu J; Rhodes C; Nie Y; Zhang F
    Am J Bioeth; 2017 May; 17(5):34-45. PubMed ID: 28430065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge, attitudes, ethical and social perspectives towards fecal microbiota transplantation (FMT) among Jordanian healthcare providers.
    Al-Bakri AG; Akour AA; Al-Delaimy WK
    BMC Med Ethics; 2021 Feb; 22(1):19. PubMed ID: 33639935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donors' experiences and attitudes of fecal microbiota transplantation: An empirical bioethics study from China.
    Ma Y; Ke D; Li D; Zhang Q
    Imeta; 2022 Dec; 1(4):e62. PubMed ID: 38867907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical issues in using ambient intelligence in health-care settings.
    Martinez-Martin N; Luo Z; Kaushal A; Adeli E; Haque A; Kelly SS; Wieten S; Cho MK; Magnus D; Fei-Fei L; Schulman K; Milstein A
    Lancet Digit Health; 2021 Feb; 3(2):e115-e123. PubMed ID: 33358138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cautions for Extending Fecal Microbiota Transplantation to Other Therapeutic Uses.
    Rhodes R; Sacks H
    Am J Bioeth; 2017 May; 17(5):46-48. PubMed ID: 28430066
    [No Abstract]   [Full Text] [Related]  

  • 6. Physicians Must Discuss Potential Long-Term Risks of Fecal Microbiota Transplantation to Ensure Informed Consent.
    Bunnik EM; Aarts N; Chen LA
    Am J Bioeth; 2017 May; 17(5):61-63. PubMed ID: 28430073
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of the implementation of a multidisciplinary programme of faecal microbiota transplantation by colonoscopy for the treatment of recurrent Clostridium difficile infection.
    López-Sanromán A; Rodríguez de Santiago E; Cobo Reinoso J; Del Campo Moreno R; Foruny Olcina JR; García Fernández S; García García de Paredes A; Aguilera Castro L; Ferre Aracil C; Albillos Martínez A
    Gastroenterol Hepatol; 2017 Nov; 40(9):605-614. PubMed ID: 28433406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Microbiota Transplantation for Refractory and Recurrent
    Bang BW; Park JS; Kim HK; Shin YW; Kwon KS; Kwon HY; Baek JH; Lee JS
    Korean J Gastroenterol; 2017 Apr; 69(4):226-231. PubMed ID: 28449424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
    Jacob V; Crawford C; Cohen-Mekelburg S; Viladomiu M; Putzel GG; Schneider Y; Chabouni F; OʼNeil S; Bosworth B; Woo V; Ajami NJ; Petrosino JF; Gerardin Y; Kassam Z; Smith M; Iliev ID; Sonnenberg GF; Artis D; Scherl E; Longman RS
    Inflamm Bowel Dis; 2017 Jun; 23(6):903-911. PubMed ID: 28445246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing Recurrence of C. difficile Infection.
    Dieterle MG; Young VB
    Cell; 2017 Apr; 169(3):375. PubMed ID: 28431238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracking microbial colonization in fecal microbiota transplantation experiments via genome-resolved metagenomics.
    Lee STM; Kahn SA; Delmont TO; Shaiber A; Esen ÖC; Hubert NA; Morrison HG; Antonopoulos DA; Rubin DT; Eren AM
    Microbiome; 2017 May; 5(1):50. PubMed ID: 28473000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Chinese clinicians face ethical and social challenges in fecal microbiota transplantation: a questionnaire study.
    Ma Y; Yang J; Cui B; Xu H; Xiao C; Zhang F
    BMC Med Ethics; 2017 May; 18(1):39. PubMed ID: 28569156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal microbiota transplantation outcomes in immunocompetent and immunocompromised patients: A single-center experience.
    Alrabaa S; Jariwala R; Zeitler K; Montero J
    Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28513974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Meighani A; Hart BR; Bourgi K; Miller N; John A; Ramesh M
    Dig Dis Sci; 2017 Oct; 62(10):2870-2875. PubMed ID: 28451916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gut Microbiota and Autism Spectrum Disorders.
    Li Q; Han Y; Dy ABC; Hagerman RJ
    Front Cell Neurosci; 2017; 11():120. PubMed ID: 28503135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Retrospective Comparison of Fecal Microbial Transplantation Methods for Recurrent Clostridium Difficile Infection.
    Cohen NA; Livovsky DM; Yaakobovitch S; Ben Yehoyada M; Ben Ami R; Adler A; Guzner-Gur H; Goldin E; Santo ME; Halpern Z; Paz K; Maharshak N
    Isr Med Assoc J; 2016 Oct; 18(10):594-599. PubMed ID: 28471618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice.
    Ekmekciu I; von Klitzing E; Fiebiger U; Escher U; Neumann C; Bacher P; Scheffold A; Kühl AA; Bereswill S; Heimesaat MM
    Front Immunol; 2017; 8():397. PubMed ID: 28469619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile.
    Curry SR
    Clin Lab Med; 2017 Jun; 37(2):341-369. PubMed ID: 28457354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods and Reporting Studies Assessing Fecal Microbiota Transplantation: A Systematic Review.
    Bafeta A; Yavchitz A; Riveros C; Batista R; Ravaud P
    Ann Intern Med; 2017 Jul; 167(1):34-39. PubMed ID: 28531908
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.